DVAX
Price
$10.46
Change
-$0.00 (-0.00%)
Updated
Oct 14 closing price
16 days until earnings call
SUPN
Price
$32.92
Change
-$0.00 (-0.00%)
Updated
Oct 14 closing price
21 days until earnings call
Ad is loading...

DVAX vs SUPN

Header iconDVAX vs SUPN Comparison
Open Charts DVAX vs SUPNBanner chart's image
Dynavax Technologies
Price$10.46
Change-$0.00 (-0.00%)
Volume$1.04M
CapitalizationN/A
Supernus Pharmaceuticals
Price$32.92
Change-$0.00 (-0.00%)
Volume$230.4K
CapitalizationN/A
View a ticker or compare two or three
DVAX vs SUPN Comparison Chart
Loading...
DVAX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SUPN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
DVAX vs. SUPN commentary
Oct 16, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DVAX is a Hold and SUPN is a StrongBuy.

COMPARISON
Comparison
Oct 16, 2024
Stock price -- (DVAX: $10.46 vs. SUPN: $32.92)
Brand notoriety: DVAX and SUPN are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: DVAX: 50% vs. SUPN: 51%
Market capitalization -- DVAX: $1.62B vs. SUPN: $1.84B
DVAX [@Pharmaceuticals: Other] is valued at $1.62B. SUPN’s [@Pharmaceuticals: Other] market capitalization is $1.84B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.36B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DVAX’s FA Score shows that 1 FA rating(s) are green whileSUPN’s FA Score has 1 green FA rating(s).

  • DVAX’s FA Score: 1 green, 4 red.
  • SUPN’s FA Score: 1 green, 4 red.
According to our system of comparison, SUPN is a better buy in the long-term than DVAX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DVAX’s TA Score shows that 5 TA indicator(s) are bullish while SUPN’s TA Score has 6 bullish TA indicator(s).

  • DVAX’s TA Score: 5 bullish, 5 bearish.
  • SUPN’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, SUPN is a better buy in the short-term than DVAX.

Price Growth

DVAX (@Pharmaceuticals: Other) experienced а -2.88% price change this week, while SUPN (@Pharmaceuticals: Other) price change was +2.68% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +8.21%. For the same industry, the average monthly price growth was +10.22%, and the average quarterly price growth was -2.43%.

Reported Earning Dates

DVAX is expected to report earnings on Feb 20, 2025.

SUPN is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+8.21% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SUPN($1.84B) has a higher market cap than DVAX($1.62B). SUPN has higher P/E ratio than DVAX: SUPN (1677.00) vs DVAX (31.63). SUPN YTD gains are higher at: 13.753 vs. DVAX (-25.179). SUPN has higher annual earnings (EBITDA): 90M vs. DVAX (9.67M). DVAX has more cash in the bank: 742M vs. SUPN (255M). SUPN has less debt than DVAX: SUPN (41.5M) vs DVAX (257M). SUPN has higher revenues than DVAX: SUPN (608M) vs DVAX (232M).
DVAXSUPNDVAX / SUPN
Capitalization1.62B1.84B88%
EBITDA9.67M90M11%
Gain YTD-25.17913.753-183%
P/E Ratio31.631677.002%
Revenue232M608M38%
Total Cash742M255M291%
Total Debt257M41.5M619%
FUNDAMENTALS RATINGS
DVAX vs SUPN: Fundamental Ratings
DVAX
SUPN
OUTLOOK RATING
1..100
313
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
95
Overvalued
PROFIT vs RISK RATING
1..100
5978
SMR RATING
1..100
8689
PRICE GROWTH RATING
1..100
7645
P/E GROWTH RATING
1..100
51
SEASONALITY SCORE
1..100
7550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DVAX's Valuation (81) in the Biotechnology industry is in the same range as SUPN (95) in the Pharmaceuticals Other industry. This means that DVAX’s stock grew similarly to SUPN’s over the last 12 months.

DVAX's Profit vs Risk Rating (59) in the Biotechnology industry is in the same range as SUPN (78) in the Pharmaceuticals Other industry. This means that DVAX’s stock grew similarly to SUPN’s over the last 12 months.

DVAX's SMR Rating (86) in the Biotechnology industry is in the same range as SUPN (89) in the Pharmaceuticals Other industry. This means that DVAX’s stock grew similarly to SUPN’s over the last 12 months.

SUPN's Price Growth Rating (45) in the Pharmaceuticals Other industry is in the same range as DVAX (76) in the Biotechnology industry. This means that SUPN’s stock grew similarly to DVAX’s over the last 12 months.

SUPN's P/E Growth Rating (1) in the Pharmaceuticals Other industry is in the same range as DVAX (5) in the Biotechnology industry. This means that SUPN’s stock grew similarly to DVAX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DVAXSUPN
RSI
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
71%
Bearish Trend 2 days ago
74%
Momentum
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
72%
MACD
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
73%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
72%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
71%
Advances
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 8 days ago
72%
Declines
ODDS (%)
Bearish Trend 6 days ago
81%
Bearish Trend 6 days ago
67%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 6 days ago
80%
Aroon
ODDS (%)
Bullish Trend 2 days ago
84%
N/A
View a ticker or compare two or three
Ad is loading...
DVAX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SUPN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X66046.1250003194.750000
+5.08%
Bitcoin cryptocurrency
GME21.330.50
+2.40%
GameStop Corp
AAPL231.403.85
+1.69%
Apple
SPY584.324.74
+0.82%
SPDR® S&P 500® ETF Trust
TSLA219.161.36
+0.62%
Tesla

DVAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, DVAX has been loosely correlated with ACET. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if DVAX jumps, then ACET could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DVAX
1D Price
Change %
DVAX100%
+0.29%
ACET - DVAX
39%
Loosely correlated
-0.72%
SNDL - DVAX
35%
Loosely correlated
+0.50%
SUPN - DVAX
32%
Poorly correlated
-0.24%
PETQ - DVAX
28%
Poorly correlated
+0.03%
ALKS - DVAX
28%
Poorly correlated
+0.55%
More

SUPN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SUPN has been loosely correlated with PETQ. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if SUPN jumps, then PETQ could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SUPN
1D Price
Change %
SUPN100%
-0.24%
PETQ - SUPN
42%
Loosely correlated
+0.03%
AMPH - SUPN
35%
Loosely correlated
+3.62%
DVAX - SUPN
32%
Poorly correlated
+0.29%
AMRX - SUPN
30%
Poorly correlated
+0.82%
COLL - SUPN
28%
Poorly correlated
+0.72%
More